Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs The Travelers Companies Inc. Common Stock (TRV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs The Travelers Companies Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.27 (market cap $12.58B), while The Travelers Companies Inc. Common Stock trades at $368.58 (market cap $77.23B). The key difference: The Travelers Companies Inc. Common Stock is far larger — about 6.1× Halozyme Therapeutics Inc. Common Stock's market cap, and The Travelers Companies Inc. Common Stock pays a 1.35% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and The Travelers Companies Inc. Common Stock for 1 Days on average.
| HALO | TRV | |
|---|---|---|
Market Cap | $12.58B | $77.23B |
Volume | 2,179,278 | 1,078,682 |
Sector | Health | Financials |
52-Week High | $115.22 | $397.22 |
52-Week Low | $61.63 | $261.57 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $85.82B |
Dividend Yield | — | 1.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About The Travelers Companies Inc. Common Stock
The Travelers Companies provides property and casualty insurance for individuals, businesses, and organizations. Its products include auto, home, and commercial coverage.
Read more on TRV →
